A US-Based, Injectables-Focused CDMO with Available Capacity and End-to-End Capabilities
Ryan Downey, Director of Customer Operations, outlines August Bioservices’ capabilities for its customers and what it means to work with them.
- They focus on sterile injectables in multiple container sizes from vials to syringes to flexible IV bags— coupled with an analytical services department.
- The current CDMO market is constrained for those who need the capacity to start their innovative work, which is where August Bioservices comes in.
- With robust tools and a strong team, they can solve difficult challenges with formulation, commercial configuration, the timing of a project, and analytical characterizations.
Video Player is loading.
Recent Videos
Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations
From Discovery to Delivery: How Piramal Pharma Limited is Strengthening its Drug Development Capabilities
Inside Experic: Revolutionizing CDMO & Clinical Packaging Services
Gaylord Chemical is Now gChem
BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
Driving Innovation in Drug Delivery: Stevanato Group’s Integrated Solutions for Evolving Patient Needs
Major Growth & Investment at Pace® Life Sciences
Safe, Smart, and Sustainable Packaging for the Healthcare Industry
From Early Development to Commercialization: Strategies for Successful Cell Therapy Manufacturing
Related Content
